Educational grant support for this session is provided by Boehringer Ingelheim Pharmaceuticals, Inc.
and sponsored by Med Learning Group. This is not an official program of the American College of Rheumatology.
Wednesday, October 29, 2025
11:15 AM – 11:30 AM CT Registration & Lunch
11:30 AM – 1:00 PM CT CE Symposium
Marriott Marquis Chicago
2121 S. Prairie Avenue
Chicago, Illinois 60616
Meeting Room: Great Lakes Ballroom AB
PROGRAM FEATURES
- Interactive case-based presentation
- Downloadable video case
- Online personalized quality-improvement poster-generation portal
PRESENTING FACULTY
 |
Kristin B. Highland, MD, MSCR Professor of Medicine Cleveland Clinic Cleveland, Ohio |
PROGRAM OVERVIEW
We are pleased to present an innovative satellite symposium focused on pathophysiology, clinical features, and challenges associated with fibrotic interstitial lung diseases (F-ILDs) such as idiopathic pulmonary fibrosis (IPF), pulmonary fibrosis related to other conditions (PPF), and systemic autoimmune disease-related interstitial lung disease (SARD-ILD). This event aims to enhance the diagnostic precision for these conditions, analyze findings from clinical trials on new and emerging therapies, and promote the importance of multidisciplinary collaboration for effective management of F-ILDs.
TARGET AUDIENCE
This activity is designed to meet the educational needs of rheumatologists.
LEARNING OBJECTIVES:
- Describe the pathophysiology, clinical characteristics, and burdens associated with F-ILDs including IPF, PPF, and SARD-ILD
- Improve diagnostic accuracy of F-ILDs including IPF, PPF, and SARD-ILD
- Interpret results from clinical trials assessing new and emerging treatment options for F-ILDs including IPF, PPF, and SARD-ILD
- Implement multidisciplinary teamwork essential for comprehensive management of F-ILDs including IPF, PPF, and SARD-ILD
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
